Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 35.1k | $3.33 | $116.9k | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 280k | $7.05 | $2M | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 109.6k | $1.94 | $212.6k | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 28.8k | $1.04 | $29.9k | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 210k | $0.96 | $201.6k | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 75k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 35.1k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 280k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 109.6k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 28.8k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 210k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 75k | $5.76 | $432k | | 10/02/2023 |
07/03/2023 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 7.1k | $0.36 | $2.5k | | 07/03/2023 |
02/21/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 210k | $0.96 | $201.6k | | 02/21/2023 |
01/03/2023 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 4.4k | $1.02 | $4.5k | | 01/03/2023 |
07/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 28.8k | $1.04 | $29.9k | | 07/28/2022 |
07/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 43.1k | $0.00 | $0 | | 07/28/2022 |
03/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 2.5k | $1.40 | $3.5k | | 03/24/2022 |
03/25/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 356 | $1.45 | $516.2 | | 03/24/2022 |
03/25/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 5 | $1.48 | $7.4 | | 03/24/2022 |
03/25/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 2.1k | $1.49 | $3.2k | | 03/24/2022 |
03/24/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 3 | $1.45 | $4.4 | | 03/24/2022 |
01/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 2.5k | $1.65 | $4.1k | | 01/27/2022 |
01/27/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 5k | $1.70 | $8.5k | | 01/27/2022 |
01/27/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 5k | $1.80 | $9k | | 01/27/2022 |
01/20/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 109.6k | $1.94 | $212.6k | | 01/20/2022 |
01/03/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 29.9k | $0.00 | $0 | | 01/03/2022 |
02/11/2021 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 280k | $7.05 | $2M | | 02/11/2021 |
03/17/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 35.1k | $3.33 | $116.9k | | 03/17/2020 |
03/17/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 35.1k | $3.33 | $116.9k | | 03/17/2020 |
09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 75k | $5.76 | $432k | | 09/12/2019 |
09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 75k | $5.76 | $432k | | 09/12/2019 |
06/07/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 42.6k | $0.00 | $0 | | 06/07/2019 |
06/07/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 4.5k | $0.00 | $0 | By family trust. | 06/07/2019 |
06/07/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 1.8k | $0.00 | $0 | By child. | 06/07/2019 |
|